NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Just maybe because the trial is for glioblastoma which is far, far worse than the many other types of brain cancers included in the 5 year statistic which you quoted. Just to give you what wiki says on this:

...Despite maximum treatment, the cancer usually recurs.[3] The most common length of survival following diagnosis is 12 to 15 months with less than 3% to 5% of people surviving longer than five years.[2][3] Without treatment survival is typically 3 months.[9] I

Thanks for playing guy, better luck next time - but you might want to try getting a clue before posting 'information' that you think is news to longs.